Your browser is no longer supported. Please, upgrade your browser.
ALPN [NASD]
Alpine Immune Sciences, Inc.
Index- P/E- EPS (ttm)-1.76 Insider Own1.10% Shs Outstand24.72M Perf Week-6.57%
Market Cap255.71M Forward P/E- EPS next Y-1.47 Insider Trans- Shs Float21.48M Perf Month-36.87%
Income-41.50M PEG- EPS next Q-0.30 Inst Own52.80% Short Float4.77% Perf Quarter-20.66%
Sales24.60M P/S10.39 EPS this Y41.20% Inst Trans0.24% Short Ratio9.57 Perf Half Y-4.09%
Book/sh4.97 P/B1.75 EPS next Y15.60% ROA-24.90% Target Price20.67 Perf Year-24.85%
Cash/sh6.13 P/C1.42 EPS next 5Y- ROE-58.90% 52W Range7.87 - 15.14 Perf YTD-37.33%
Dividend- P/FCF- EPS past 5Y-12.60% ROI-39.80% 52W High-41.68% Beta1.93
Dividend %- Quick Ratio2.90 Sales past 5Y80.10% Gross Margin- 52W Low12.20% ATR1.02
Employees57 Current Ratio2.90 Sales Q/Q347.40% Oper. Margin- RSI (14)35.64 Volatility12.33% 9.30%
OptionableYes Debt/Eq0.07 EPS Q/Q-98.10% Profit Margin- Rel Volume0.26 Prev Close8.68
ShortableYes LT Debt/Eq0.04 EarningsNov 11 AMC Payout- Avg Volume106.93K Price8.83
Recom1.50 SMA20-19.77% SMA50-26.38% SMA200-18.10% Volume2,746 Change1.73%
Dec-21-20Initiated H.C. Wainwright Buy $21
Aug-26-20Initiated Cowen Outperform
Jan-04-22 04:05PM  
Dec-29-21 04:13AM  
Dec-16-21 08:00AM  
Nov-22-21 04:05PM  
Nov-10-21 04:05PM  
Nov-08-21 08:05AM  
Nov-04-21 03:01PM  
Oct-02-21 08:06AM  
Sep-28-21 09:42AM  
Sep-24-21 10:29AM  
Sep-22-21 12:04PM  
08:22AM  
07:01AM  
Sep-15-21 08:05AM  
Sep-07-21 04:05PM  
Aug-18-21 06:04AM  
Aug-10-21 05:45PM  
04:05PM  
Aug-04-21 08:00AM  
Aug-03-21 03:00PM  
Jul-30-21 09:55AM  
Jul-24-21 03:25AM  
Jul-01-21 10:51AM  
Jun-30-21 08:00AM  
Jun-24-21 08:00AM  
Jun-13-21 05:28AM  
Jun-08-21 08:00AM  
01:12AM  
Jun-04-21 04:05PM  
Jun-03-21 08:14AM  
01:20AM  
Jun-02-21 04:05PM  
08:00AM  
May-23-21 06:43AM  
May-20-21 04:47AM  
May-19-21 05:10PM  
May-18-21 04:05PM  
May-13-21 06:45PM  
04:05PM  
May-06-21 03:00PM  
May-05-21 01:41AM  
Apr-28-21 04:05PM  
Apr-16-21 08:28AM  
Apr-12-21 08:00AM  
Mar-21-21 03:30AM  
Mar-19-21 12:00AM  
Mar-18-21 05:35PM  
04:05PM  
02:30PM  
Mar-11-21 04:05PM  
Mar-10-21 04:30PM  
Feb-22-21 04:05PM  
Feb-03-21 11:36PM  
Jan-06-21 08:00AM  
Jan-01-21 07:04AM  
Dec-21-20 10:07AM  
Dec-20-20 11:29PM  
Dec-17-20 08:00AM  
Dec-11-20 10:23PM  
08:00AM  
Dec-08-20 08:35AM  
Nov-24-20 04:05PM  
Nov-16-20 04:05PM  
Nov-15-20 07:03AM  
Nov-12-20 04:05PM  
02:30PM  
Nov-05-20 04:05PM  
Oct-28-20 06:32AM  
Sep-15-20 04:05PM  
Sep-08-20 04:05PM  
08:57AM  
Aug-26-20 09:42AM  
Aug-11-20 04:05PM  
Aug-05-20 04:05PM  
Aug-04-20 04:05PM  
Jul-24-20 09:15AM  
Jul-22-20 06:45AM  
Jul-08-20 09:05AM  
07:35AM  
Jun-25-20 12:09PM  
Jun-24-20 08:00AM  
Jun-19-20 11:27AM  
09:32AM  
07:41AM  
Jun-18-20 10:22AM  
08:00AM  
Jun-15-20 08:00AM  
Jun-11-20 06:57AM  
Jun-10-20 03:44PM  
Jun-08-20 08:00AM  
Jun-04-20 08:00AM  
May-29-20 08:00AM  
May-26-20 04:05PM  
May-16-20 08:11AM  
May-14-20 04:01PM  
Apr-27-20 09:00AM  
Apr-20-20 04:05PM  
Apr-13-20 06:15AM  
Apr-07-20 07:06AM  
Mar-30-20 04:01PM  
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated autoimmune/inflammatory diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the research, development, and commercialization of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rickey James PaulSenior VP and CFODec 31Sale13.9217,013236,7567,014Jan 04 05:40 PM
CONWAY ROBERT EDirectorSep 21Buy9.8010,00097,96635,000Sep 23 08:31 PM
Cui XiangminDirectorSep 17Buy9.401,542,55314,499,9984,708,288Sep 21 05:12 PM
ORBIMED ADVISORS LLCDirectorSep 17Buy9.401,010,6379,499,9883,656,061Sep 21 06:42 PM
Decheng Capital China Life Sci10% OwnerSep 17Buy9.401,542,55314,499,9984,708,288Sep 21 06:39 PM
Thompson Peter A.DirectorSep 17Buy9.401,010,6379,499,9883,656,061Sep 21 06:38 PM
Alpine ImmunoSciences, L.P.10% OwnerSep 17Sale9.40400,0003,760,0002,600,980Sep 21 05:18 PM
GOLD MITCHELLExecutive Chairman and CEOSep 17Sale9.40400,0003,760,0002,600,980Sep 21 05:16 PM
GOLD MITCHELLExecutive Chairman and CEOSep 17Sale10.0145,262452,964109,387Sep 21 05:16 PM
Venkatesan JayDirectorSep 17Sale9.40400,0003,760,0002,600,980Sep 21 05:14 PM
GOLD MITCHELLExecutive Chairman and CEOSep 16Sale10.006,76867,696154,649Sep 17 06:06 PM
GOLD MITCHELLExecutive Chairman and CEOSep 15Sale10.003,48434,840161,417Sep 17 06:06 PM
GOLD MITCHELLExecutive Chairman and CEOJun 28Sale10.003,47934,792164,901Jun 29 05:13 PM
GOLD MITCHELLExecutive Chairman and CEOJun 25Sale10.019,47394,865168,380Jun 29 05:13 PM
GOLD MITCHELLExecutive Chairman and CEOMay 20Sale15.001,22118,316177,853May 21 05:16 PM
GOLD MITCHELLExecutive Chairman and CEOMay 19Sale15.0350,965765,917179,074May 21 05:16 PM
GOLD MITCHELLExecutive Chairman and CEOMay 13Sale11.5210,000115,169230,039May 14 05:17 PM
GOLD MITCHELLExecutive Chairman and CEOMay 12Sale11.6810,000116,842240,039May 14 05:17 PM
GOLD MITCHELLExecutive Chairman and CEOApr 14Sale10.5210,000105,200250,039Apr 15 06:09 PM
GOLD MITCHELLExecutive Chairman and CEOApr 13Sale10.0710,000100,714260,039Apr 15 06:09 PM
Venkatesan JayDirectorMar 31Option Exercise3.627,65027,718218,063Apr 23 06:14 PM
Venkatesan JayDirectorMar 30Option Exercise4.097,65031,288210,413Apr 23 06:14 PM
GOLD MITCHELLExecutive Chairman and CEOMar 05Sale12.9910,000129,875270,039Mar 08 05:01 PM
GOLD MITCHELLExecutive Chairman and CEOMar 04Sale13.0110,000130,108280,039Mar 08 05:01 PM
GOLD MITCHELLExecutive Chairman and CEOFeb 02Sale11.7410,000117,381290,039Feb 03 05:01 PM
GOLD MITCHELLExecutive Chairman and CEOFeb 01Sale12.8710,000128,665300,039Feb 03 05:01 PM